MN1 Polyclonal Antibody

Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4;22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis.

The MN1 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of MN1 protein expression in various biological samples. This antibody is produced using state-of-the-art technology, ensuring exceptional quality and reliability.

The MN1 Polyclonal Antibody exhibits a high affinity towards the MN1 protein, enabling accurate and precise detection even at low concentrations. It has been extensively validated in multiple experimental settings, including Western blotting, immunohistochemistry, and immunofluorescence.

With its exceptional specificity, the MN1 Polyclonal Antibody offers researchers a valuable tool for studying the role of MN1 protein in various cellular processes and disease states. Its reliable performance and reproducibility make it an ideal choice for both basic research and clinical applications.

The MN1 Polyclonal Antibody is supplied in a convenient and ready-to-use format, allowing for easy integration into existing laboratory protocols. It is provided in a liquid formulation, ensuring stability and ease of use. Each batch of the antibody undergoes rigorous quality control testing to ensure consistent performance and reliability.

In summary, the MN1 Polyclonal Antibody is a highly specific and sensitive tool that enables accurate detection and analysis of MN1 protein expression. Its exceptional quality, reliability, and ease of use make it an indispensable asset for researchers in the field of molecular biology and biomedical sciences.